(TRIN) Trinity Capital - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8964423086
Stock: Business Loans, Equipment Finance, Private Equity
Total Rating 38
Risk 78
Buy Signal -0.45
| Risk 5d forecast | |
|---|---|
| Volatility | 19.7% |
| Relative Tail Risk | -1.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | -0.91 |
| Character TTM | |
|---|---|
| Beta | 0.459 |
| Beta Downside | 0.352 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.58% |
| CAGR/Max DD | 1.52 |
EPS (Earnings per Share)
Revenue
Description: TRIN Trinity Capital March 05, 2026
Trinity Capital Inc. (TRIN) operates as a business development company (BDC).
BDCs are a type of closed-end investment company that invests in small and mid-sized private companies, often providing debt and equity financing.
TRIN specializes in term loans, equipment financing, and private equity investments across sectors like technology and life sciences.
The company aims to deliver consistent returns to investors by facilitating access to the private credit market.
Founded in 2019, TRIN is headquartered in Phoenix, Arizona.
For more detailed financial analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Venture debt demand impacts loan origination volume
- Interest rate fluctuations affect net investment income
- Credit quality of portfolio companies drives loss provisions
- Technology sector growth influences investment opportunities
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 135.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 20.66 > 1.0 |
| NWC/Revenue: 13.42% < 20% (prev -2.42%; Δ 15.84% < -1%) |
| CFO/TA 0.03 > 3% & CFO 69.4m > Net Income 135.6m |
| Net Debt (1.29b) to EBITDA (216.2m): 5.98 < 3 |
| Current Ratio: 22.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.0m) vs 12m ago 21.43% < -2% |
| Gross Margin: 81.61% > 18% (prev 0.80%; Δ 8081 % > 0.5%) |
| Asset Turnover: 13.13% > 50% (prev 12.31%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 0.81 > 6 (EBITDA TTM 216.2m / Interest Expense TTM 80.6m) |
Altman Z'' 0.29
| A: 0.02 (Total Current Assets 39.2m - Total Current Liabilities 1.72m) / Total Assets 2.48b |
| B: -0.00 (Retained Earnings -6.43m / Total Assets 2.48b) |
| C: 0.03 (EBIT TTM 64.9m / Avg Total Assets 2.13b) |
| D: -0.00 (Book Value of Equity -6.34m / Total Liabilities 1.39b) |
| Altman-Z'' Score: 0.29 = B |
Beneish M
| DSRI: 0.90 (Receivables 19.0m/16.5m, Revenue 279.5m/218.4m) |
| GMI: 0.98 (GM 81.61% / 80.36%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.28 (Revenue 279.5m / 218.4m) |
| TATA: 0.03 (NI 135.6m - CFO 69.4m) / TA 2.48b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of TRIN shares?
As of March 09, 2026, the stock is trading at USD 14.91 with a total of 1,033,769 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -6.73%, over three months by +3.20% and over the past year by +8.62%.
Over the past week, the price has changed by +0.00%, over one month by -6.73%, over three months by +3.20% and over the past year by +8.62%.
Is TRIN a buy, sell or hold?
Trinity Capital has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy TRIN.
- StrongBuy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the TRIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.6 | 11.4% |
| Analysts Target Price | 16.6 | 11.4% |
TRIN Fundamental Data Overview March 05, 2026
P/E Trailing = 6.7421
P/E Forward = 7.1736
P/S = 4.0344
P/B = 1.1312
P/EG = 5.256
Revenue TTM = 279.5m USD
EBIT TTM = 64.9m USD
EBITDA TTM = 216.2m USD
Long Term Debt = 1.31b USD (estimated: total debt 1.31b - short term 1.72m)
Short Term Debt = 1.72m USD (from shortTermDebt, last quarter)
Debt = 1.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.29b USD (from netDebt column, last quarter)
Enterprise Value = 2.42b USD (1.13b + Debt 1.31b - CCE 19.1m)
Interest Coverage Ratio = 0.81 (Ebit TTM 64.9m / Interest Expense TTM 80.6m)
EV/FCF = 35.14x (Enterprise Value 2.42b / FCF TTM 68.9m)
FCF Yield = 2.85% (FCF TTM 68.9m / Enterprise Value 2.42b)
FCF Margin = 24.64% (FCF TTM 68.9m / Revenue TTM 279.5m)
Net Margin = 48.51% (Net Income TTM 135.6m / Revenue TTM 279.5m)
Gross Margin = 81.61% ((Revenue TTM 279.5m - Cost of Revenue TTM 51.4m) / Revenue TTM)
Gross Margin QoQ = none% (prev 68.32%)
Tobins Q-Ratio = 0.97 (Enterprise Value 2.42b / Total Assets 2.48b)
Interest Expense / Debt = 1.82% (Interest Expense 23.9m / Debt 1.31b)
Taxrate = 21.0% (US default 21%)
NOPAT = 51.3m (EBIT 64.9m * (1 - 21.00%))
Current Ratio = 22.79 (Total Current Assets 39.2m / Total Current Liabilities 1.72m)
Debt / Equity = 1.20 (Debt 1.31b / totalStockholderEquity, last quarter 1.09b)
Debt / EBITDA = 5.98 (Net Debt 1.29b / EBITDA 216.2m)
Debt / FCF = 18.77 (Net Debt 1.29b / FCF TTM 68.9m)
Total Stockholder Equity = 962.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.37% (Net Income 135.6m / Total Assets 2.48b)
RoE = 14.09% (Net Income TTM 135.6m / Total Stockholder Equity 962.3m)
RoCE = 2.86% (EBIT 64.9m / Capital Employed (Equity 962.3m + L.T.Debt 1.31b))
RoIC = 2.59% (NOPAT 51.3m / Invested Capital 1.98b)
WACC = 4.29% (E(1.13b)/V(2.44b) * Re(7.61%) + D(1.31b)/V(2.44b) * Rd(1.82%) * (1-Tc(0.21)))
Discount Rate = 7.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 26.54%
[DCF] Terminal Value 83.81% ; FCFF base≈68.9m ; Y1≈55.3m ; Y5≈37.7m
[DCF] Fair Price = N/A (negative equity: EV 1.16b - Net Debt 1.29b = -134.8m; debt exceeds intrinsic value)
EPS Correlation: -42.56 | EPS CAGR: -2.42% | SUE: 0.14 | # QB: 0
Revenue Correlation: 84.76 | Revenue CAGR: 88.39% | SUE: -1.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.52 | Chg7d=-0.004 | Chg30d=-0.004 | Revisions Net=+2 | Analysts=8
EPS current Year (2026-12-31): EPS=2.07 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=+0 | Growth EPS=-0.7% | Growth Revenue=+21.6%
EPS next Year (2027-12-31): EPS=2.05 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=-1 | Growth EPS=-0.6% | Growth Revenue=+8.2%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -6.9% (Discount Rate 7.9% - Earnings Yield 14.8%)
[Growth] Growth Spread = +33.6% (Analyst 26.7% - Implied -6.9%)
P/E Forward = 7.1736
P/S = 4.0344
P/B = 1.1312
P/EG = 5.256
Revenue TTM = 279.5m USD
EBIT TTM = 64.9m USD
EBITDA TTM = 216.2m USD
Long Term Debt = 1.31b USD (estimated: total debt 1.31b - short term 1.72m)
Short Term Debt = 1.72m USD (from shortTermDebt, last quarter)
Debt = 1.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.29b USD (from netDebt column, last quarter)
Enterprise Value = 2.42b USD (1.13b + Debt 1.31b - CCE 19.1m)
Interest Coverage Ratio = 0.81 (Ebit TTM 64.9m / Interest Expense TTM 80.6m)
EV/FCF = 35.14x (Enterprise Value 2.42b / FCF TTM 68.9m)
FCF Yield = 2.85% (FCF TTM 68.9m / Enterprise Value 2.42b)
FCF Margin = 24.64% (FCF TTM 68.9m / Revenue TTM 279.5m)
Net Margin = 48.51% (Net Income TTM 135.6m / Revenue TTM 279.5m)
Gross Margin = 81.61% ((Revenue TTM 279.5m - Cost of Revenue TTM 51.4m) / Revenue TTM)
Gross Margin QoQ = none% (prev 68.32%)
Tobins Q-Ratio = 0.97 (Enterprise Value 2.42b / Total Assets 2.48b)
Interest Expense / Debt = 1.82% (Interest Expense 23.9m / Debt 1.31b)
Taxrate = 21.0% (US default 21%)
NOPAT = 51.3m (EBIT 64.9m * (1 - 21.00%))
Current Ratio = 22.79 (Total Current Assets 39.2m / Total Current Liabilities 1.72m)
Debt / Equity = 1.20 (Debt 1.31b / totalStockholderEquity, last quarter 1.09b)
Debt / EBITDA = 5.98 (Net Debt 1.29b / EBITDA 216.2m)
Debt / FCF = 18.77 (Net Debt 1.29b / FCF TTM 68.9m)
Total Stockholder Equity = 962.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.37% (Net Income 135.6m / Total Assets 2.48b)
RoE = 14.09% (Net Income TTM 135.6m / Total Stockholder Equity 962.3m)
RoCE = 2.86% (EBIT 64.9m / Capital Employed (Equity 962.3m + L.T.Debt 1.31b))
RoIC = 2.59% (NOPAT 51.3m / Invested Capital 1.98b)
WACC = 4.29% (E(1.13b)/V(2.44b) * Re(7.61%) + D(1.31b)/V(2.44b) * Rd(1.82%) * (1-Tc(0.21)))
Discount Rate = 7.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 26.54%
[DCF] Terminal Value 83.81% ; FCFF base≈68.9m ; Y1≈55.3m ; Y5≈37.7m
[DCF] Fair Price = N/A (negative equity: EV 1.16b - Net Debt 1.29b = -134.8m; debt exceeds intrinsic value)
EPS Correlation: -42.56 | EPS CAGR: -2.42% | SUE: 0.14 | # QB: 0
Revenue Correlation: 84.76 | Revenue CAGR: 88.39% | SUE: -1.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.52 | Chg7d=-0.004 | Chg30d=-0.004 | Revisions Net=+2 | Analysts=8
EPS current Year (2026-12-31): EPS=2.07 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=+0 | Growth EPS=-0.7% | Growth Revenue=+21.6%
EPS next Year (2027-12-31): EPS=2.05 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=-1 | Growth EPS=-0.6% | Growth Revenue=+8.2%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -6.9% (Discount Rate 7.9% - Earnings Yield 14.8%)
[Growth] Growth Spread = +33.6% (Analyst 26.7% - Implied -6.9%)